Global Human DNA Vaccine Market to be dominated by Oncology Application through 2028

Development of novel vaccines using recombinant DNA technology is expected to drive the growth of Global Human DNA Vaccine Market during the forecast period.


According to TechSci Research report, “Human DNA Vaccine Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Global Human DNA Vaccine market grow with an impressive CAGR in the forecast period, 2023-2028 on account of increasing incidences of different diseases.

Human DNA Vaccine involves the direct introduction of live or dead infectious agent, or components of an infectious agent into appropriate tissues of a plasmid containing the DNA sequence encoding the antigen against which it produces an immune response depending on the target antigen. These cells prevent the body by developing antibodies against antigens.

There are various benefits associated with human DNA vaccine such as higher stability, lesser production time and cost, higher levels of safety, among others which are driving the growth of human DNA vaccine market. However, stringent regulatory scenario related to the approvals and launches of human DNA vaccine can slow down the market growth in the coming years. Also, lesser adoption and awareness pertaining to human DNA vaccine especially in the emerging countries can further slowdown the market growth.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Human DNA Vaccine Market"

Global Human DNA Vaccine Market can be segmented into mode of administration, application, end user, region, and company. In terms of mode of administration, the market can be segmented into intramuscular, subcutaneous, intradermal, and others. The intradermal segment is expected to show an impressive growth in forecast period due to their immunogenicity i.e., the ability of cells/tissues to provoke an immune response in the body against antigen.


The market can be classified into four categories based on the application, oncology, tuberculosis, HIV, human papillomavirus, and others. The oncology segment dominated the market in 2022 and will continue maintaining its dominance through 2028 due to increasing prevalence of different types of cancer across the worldwide.

The market is classified into four categories based on the end user into hospitals & clinics, biotechnology & pharmaceutical companies, academic & research institutions, and others. The hospital & clinics segment dominated the market in 2022 on account of large pool of population visiting the hospitals for availing different types of treatments. Additionally, in hospitals a lot of clinical trials are also run, thereby driving segmental growth.

The leading companies operating in the Global Human DNA Vaccine Market are:

  • ELI-LILLY (Novartis Animal Health)
  • GeneOne Life Science
  • Inovio Pharmaceuticals (VGX Animal Health)
  • Genexine, Inc.
  • VIATRIS INC. (Rottapharm Biotech)
  • Takara Holdings (Takara Bio)
  • ZOETIS INC. (Fort dodge Animal Health)
  • Zydus Lifesciences Limited


Download  Free Sample Report

Customers can also request for 10% free customization on this report.


“North America is expected to dominate the global human DNA vaccine market during the forecast period on account of rising incidence of different diseases especially HIV, cancer and human papillomavirus. Besides, rise in the number of government investments and rise in the number of antibiotic resistant pathogens is expected to increase the demand for human DNA vaccine in the coming years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Human DNA Vaccine Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Mode of Administration (Intramuscular, Subcutaneous, Intradermal, Others), By Application (Oncology, Tuberculosis, HIV, Human Papillomavirus, Others), By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By Region and Competition”, has evaluated the future growth potential of Global Human DNA Vaccine Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Human DNA Vaccine Market.


Mr. Ken Mathews

708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]

Showing 1 reaction

Please check your e-mail for a link to activate your account.